Advertisement OCI Gets Brazilian FDA Approval For Monitors, Sensors - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

OCI Gets Brazilian FDA Approval For Monitors, Sensors

Opto Circuits (India) Ltd. (OCI) announced that its subsidiary Mediaid Inc. (Mediaid) has received approvals from the Brazilian FDA agency, Agencia Nacional de Vigilancia Sanitaria (ANVISA) for the marketing and sale of the Mediaid brand of patient monitors and sensors in that country and surrounding geographies.

OCI is a technology company engaged in the design, development, manufacturing, marketing and distribution of medical electronic devices and medical monitoring products employing sensing and detection techniques. The company provides its products in two categories: Health Care products and Opto Electronics Products. The company is headquartered in Bangalore, India and employs 358 people.